Guardant Health, Inc. Equity-NMS: GH

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$32.39

52W high :

$78.34

1Y :

-50.67%

5Y :

46.08%

EPS(TTM): :

-5.94

Shares O/S :

102.44 M

Market cap :

3.27 B

What is the share price of Guardant Health, Inc. today?

Guardant Health, Inc. (GH) share price as of October 11, 2022, is $51.85. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Guardant Health, Inc.?

Yes, Indian Investors can invest in the Guardant Health, Inc. (GH) Share by opening an international trading account with Angel One.

How can I purchase Guardant Health, Inc. shares in India?

Purchasing Guardant Health, Inc. (GH) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Guardant Health, Inc. (GH) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Guardant Health, Inc.?

Yes, you can purchase fractional shares of Guardant Health, Inc. (GH) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Guardant Health, Inc.?

The market capitalization of Guardant Health, Inc. on February 4, 2023, is $5.3 B.

In which sector Guardant Health, Inc. belongs?

Guardant Health, Inc. operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in Guardant Health, Inc. stocks?

In order to invest in Guardant Health, Inc. (GH) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through the use of its blood-based tests, data sets, and advanced analytics. It has developed its Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced-stage cancer. It also developed its Guardant Reveal liquid biopsy-based test for residual and recurring cancer to address the need for Stage II-II I colorectal cancer. Its Guardant360 test is a molecular diagnostic test measuring 74 cancer-related genes. Its Guardant360 CDx test is a liquid biopsy test measuring 55 cancer-related genes. Its GuardantOMNI test has a broader 500-gene panel, all of which analyze circulating tumor deoxyribonucleic acid (DNA) in the blood. The Company's tests are used by biopharmaceutical companies for a range of applications, including identifying patient populations to accelerate translational science research and clinical trial enrollment, and companion diagnostic.